RegeneRx Biopharmaceuticals Inc (OTCMKTS:RGRX) Regains Some Lost Value

[[tagnumber 0]][[tagnumber 1]]Last month we saw the stock of RegeneRx Biopharmaceuticals (OTCMKTS:EGRX) gain a lot of value after the company was covered by Rodman & Renshaw who set a twelve–month price target of $2 per share for the company stock.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Even after examining all the optimism of their report you can see why this price target is simply ludicrous by doing a simple math. [[tagnumber 6]]RGRX’s[[tagnumber 7]] current outstanding share count is 101 million, which would mean that if its price hits $2 per share the market value will come at over $200 million. Taking a quick look at the numbers contained in the company’s latest 10–K reveals another reason why this isn’t likely to happen.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $317 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $358 thousand[[tagnumber 13]] [[tagnumber 12]]current liabilities: $359 thousand[[tagnumber 13]] [[tagnumber 12]]annual revenues: $60 thousand[[tagnumber 13]] [[tagnumber 12]]annual net loss: $5.27 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Looking at these numbers and considering the projected market cap of more than $200 million you would think that they guys over at Rodman & Renshaw have lost it. Then again, the disclaimer of their report states that R&R’s parent company H. C. Wainwright & Co will seek investment and banking services compensation from [[tagnumber 6]]RGRX.[[tagnumber 7]][[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Still, the gains that were made after R&R touted the company stock have been mostly kept. The ticker did suffer a serious correction on Wednesday, but it recovered 18.52% yesterday and closed at $0.64, while a total of 159 thousand traded shares generated $101 thousand in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]][[tagnumber 6]]RGRX[[tagnumber 7]] has already regained all the value it lost by now, but can it hold the inflated market cap of $65 million much longer? [[tagnumber 2]]